<br /> Empirical Formula (Hill Notation): C21H16ClF3N4O3·C7H8SO3 CAS号: 475207-59-1 分子量: 637.03 MDL编号: MFCD08235032">
口服活性激酶抑制剂索拉非尼(BAY 43-9006)的甲苯磺酸盐,通过靶向b-Raf,c-Raf(Raf-1)以及几种参与的受体酪氨酸激酶在体外和体内发挥广谱抗癌功效新血管形成和肿瘤进展,包括血管内皮生长因子受体2/3(VEGFR-2/Flk-1/KDR,VEGFR-3),血小板衍生生长因子受体β(PDGFR-β),Flt-3,c-KIT,FGFR-1(Flt-2)和RET。
≥98% (HPLC)
powder
desiccated
white to very dark brown
DMSO: 2 mg/mL, clear
2-8°C
1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)
IVDHYUQIDRJSTI-UHFFFAOYSA-N
Danger
Aquatic Acute 1 - Aquatic Chronic 1 - Lact. - Repr. 1B - STOT RE 1
6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK 3